Early (18)F-FDG PET/CT Evaluation Shows Heterogeneous Metabolic Responses to Anti-EGFR Therapy in Patients with Metastatic Colorectal Cancer

OBJECTIVE: The aim of this pilot study was to explore intrapatient mixed metabolic response and early (18)F-FDG PET response evaluation using predefined quantification strategies in patients with advanced KRAS wild-type colorectal adenocarcinoma (mCRC) treated with cetuximab. METHODS: A (18)F-FDG PE...

Descripción completa

Detalles Bibliográficos
Autores principales: van Helden, Erik J., Hoekstra, Otto S., Boellaard, Ronald, Roth, Chantal, Mulder, Emma R., Verheul, Henk M. W., Menke-van der Houven van Oordt, C. Willemien
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4873260/
https://www.ncbi.nlm.nih.gov/pubmed/27196139
http://dx.doi.org/10.1371/journal.pone.0155178

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4873260/
https://www.ncbi.nlm.nih.gov/pubmed/27196139
http://dx.doi.org/10.1371/journal.pone.0155178

Ejemplares similares